control the diagnostic and therapeutic equipment. This is the responsibility of IBAs Dosimetry business, which has 
developed a range of tools to calibrate radiation equipment 
and verify the dose of ionizing radiation that the patient absorbs 
during medical imaging and radiotherapy. In 2022, IBA acquired Modus Medical Devices and added 
its sophisticated QA solutions to IBAs existing portfolio. The entity was rebranded as IBA QUASAR and is recognized 
for its advanced tools for MR image guidan